Sangeeta, Bhatia, MD, PhD, of the Massachusetts Institute of Technology in Cambridge, is developing a method of CRC screening using nanoparticle delivery and a urine test. Through modification, yogurt bacteria produce nanoparticles that interact with colorectal tumors after being consumed. The interaction can then be detected by a simple urine test.
The test has been demonstrated in mice, but further clinical trials in both mice and humans are still necessary, according to the report.
More articles on gastroenterology:
9 gastroenterologists in the news
Should ADR detection benchmarks be higher?
Digestive Disease Specialists join Esse Health in Missouri
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.